Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06832878 · ClinicalTrials.gov registry record · Phase 4
Postoperative Oral Tranexamic Acid in Patients Undergoing Primary Total Joint Arthroplasty
A Phase 4 study, sponsored by Mayo Clinic.
- Not yet
- Registry status
- Phase 4
- Development phase
- 101
- Enrollment target
NCT06832878: Clinical Trial Phase 4 study, sponsored by Mayo Clinic.
NCT06832878 is a Phase 4 study that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 101 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06832878, a Phase 4 study, has not yet begun recruiting, sponsored by Mayo Clinic.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 101 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the impact of an extended oral Tranexamic Acid regimen on patient reported outcome scores, time to independent ambulation, postoperative range of motion, swelling, change in hemoglobin levels, 90-day complications, readmission and reoperation.
Interventions
- DRUG Oral Tranexamic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2026-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06832878
The ClinicalTrials.gov registry entry for NCT06832878 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral Tranexamic Acid is the first listed.
NCT06832878 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06832878 about?
NCT06832878 is a clinical study titled "Postoperative Oral Tranexamic Acid in Patients Undergoing Primary Total Joint Arthroplasty". The purpose of this study is to evaluate the impact of an extended oral Tranexamic Acid regimen on patient reported outcome scores, time to independent ambulation, postoperative range of motion, swelling, change in hemoglobin levels, 90-day complications, readmission and reoperation.
What is the current status of trial NCT06832878?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 101 participants. The study started on 2026-06-01. Estimated completion is 2026-06.
What interventions are being tested in trial NCT06832878?
The interventions under investigation include: Oral Tranexamic Acid (DRUG).
Who is sponsoring clinical trial NCT06832878?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.